When do you start to lose weight on semaglutide?

Step 1: weeks one to four — appetite shifts before the scale does

The first pen of Wegovy contains the 0.25 mg dose. Its job is tolerability: giving your body time to adjust to the medicine before the dose climbs. Some people lose a kilogram or two in this opening month; others see very little movement on the scale yet. Both are normal.

What tends to change noticeably first is appetite. Many people find that their usual portion feels like too much, that the pull toward snacking between meals quietens, and that food simply occupies less mental space. That shift in hunger signalling is semaglutide doing what it is licensed to do, it acts on GLP-1 receptors involved in appetite regulation and slows the rate at which the stomach empties, so fullness arrives sooner and lasts longer.

There is a common misconception that if the scale hasn't moved dramatically by week three, the medicine isn't working. It is worth letting that thought go. The 0.25 mg starting dose is genuinely not a therapeutic weight-loss dose; it is a settling-in period. The prescriber-led titration that follows is where the sustained effect builds.

The detailed guide on when Wegovy weight loss begins explores this early phase in more depth if you want a closer look at what to expect day by day.

Step 2: months two to six, the titration window, when loss accelerates

Semaglutide is prescribed on an escalating schedule: 0.25 mg, then 0.5 mg, 1.0 mg, 1.7 mg, and finally 2.4 mg as the standard maintenance dose, with roughly four weeks at each level under prescriber guidance. As the dose rises through this window, appetite suppression deepens and most people find weight loss accelerating noticeably.

By months three to four the difference is usually visible. Energy intake falls, not through willpower but because satiety genuinely arrives earlier in a meal. The NHS semaglutide medicines page confirms this mechanism and outlines what to expect at each stage of treatment.

Gastrointestinal effects (nausea, loose stools or constipation) are most common during dose increases and often settle within one to two weeks. Your prescriber may slow the titration if they are bothersome; the timeline for weight loss adjusts accordingly. Slower titration is not failure; it is clinical sense.

For a broader sense of whether semaglutide is likely to help you, including the factors that predict a stronger response, that page pulls together the evidence clearly.

Step 3: months six to eighteen (the maintenance phase and continued loss

Once you reach the 2.4 mg maintenance dose, weight loss continues) often for a year or more, before naturally plateauing as the body reaches a new equilibrium. In the STEP 1 trial, the average reduction of around 15% of body weight was measured at 68 weeks, reflecting consistent loss across that full period rather than a single sharp drop.

Practically, this means someone starting at 100 kg might expect to lose somewhere in the region of 10 to 20 kg over the full course of treatment, though the range is wide and individual variation is real. Factors that influence outcomes include starting BMI, how well gastrointestinal side effects are managed, and whether lifestyle changes in diet and activity are sustained alongside the medicine.

NICE's recommendations for semaglutide note that if less than 5% of starting weight is lost after six months at the maintenance dose, continuing should be reviewed with the prescriber. That threshold exists as a clinical check, not as a deadline. Many people hit it easily; some take a little longer to respond fully.

If you are weighing up how Wegovy compares in practice, the evidence-based summary on Wegovy and weight loss is a good next read.

What shapes your personal timeline

No two timelines are identical. A prescriber reviewing your case considers starting weight, any relevant conditions, current medicines, and how you are tolerating each dose. These variables mean the person next to you on the same dose at the same week may be losing at a different rate, and both of you may be on track.

Protein intake, hydration, and some form of regular physical activity all support the medicine's effect; your prescriber or a dietitian can help build a plan that fits around treatment rather than fighting it. The full semaglutide guide covers how diet and activity sit alongside the medicine.

On the question of cost, which often comes up alongside timelines: private treatment prices vary by provider and dose. The Wegovy cost context page explains what legitimate pricing reflects and what a transparent all-inclusive price actually covers, which is useful context before comparing options.

If you have further questions or want to explore whether semaglutide is clinically appropriate for you, our prescribers are available seven days a week. Speak to our prescribers through a free consultation, reviewed the same day by a GPhC-registered Independent Prescriber, not an automated system.